Projects

STICHTING HET NEDERLANDS KANKER INSTITUUTANTONI VAN LEEUWENHOEK ZIEKENHUIS - Netherlands 

Project overview (since 2010-01-01):

<< previous
Start dateProjectacronymrolefundingpartners
2015-09-01Tumor cell death supports recurrence of cancer Cancer-Recurrencecoordinator2.000.0002
2015-09-01From haplotype to phenotype: a systems integration of allelic variation, chromatin state and 3D genome data HAP-PHENparticipant1.500.0001
2015-09-01Infrastructure for NMR, EM and X-rays for translational research iNEXTparticipant9.999.53425
2015-09-01Breast CAncer STratification: understanding the determinants of risk and prognosis of molecular subtypes B-CASTcoordinator5.983.35613
2014-03-01Mechanistic insights into the impact of tumor-associated neutrophils on metastatic breast cancer INFLAMETparticipant1.999.3601
2013-12-01Advanced T-cell Engineered for Cancer Therapy ATECTparticipant5.931.1515
2013-10-01The impact of chromosomal instability on health: Molecular causes and consequences of aneuploidy PLOIDYNETcoordinator3.017.79011
2013-10-01The European non-coding RNA network RNATRAINparticipant3.474.40011
2013-09-01Breast biopsy system guided by Positron Emission Mammography allowing real-time 3D visualization of tumour lesion and needle insertion guidance for higher sampling accuracy and efficiency MAMMOCAREparticipant1.077.0007
2013-05-01Towards clinical translation of new gene targeting technologies for correcting inherited mutations and empowering adoptive immunotherapy of cancer SUPERSISTparticipant5.999.9975
2013-05-01Combination therapies for personalized cancer medicine COMBATCANCERparticipant14.580.5582
2013-05-01Quantitative T cell Immunology QUANTIparticipant4.012.57012
2013-04-01Identification and functional validation of drugable targets/pathways for triple negative breast cancer TRIPLE-BCparticipant2.495.1023
2013-02-01Digital radiation therapy patient DR THERAPATparticipant3.502.0008
2013-01-01Development of mouse mutant resources for functional analyses of human diseases - Enhancing the translation of research into innovation INFRAFRONTIER-I3participant9.900.00023
2013-01-01Identification of Host Determinants for Virus Entry using a Haploid Genetic Approach VIRAL HOST FACTORSparticipant1.495.2001
2012-12-01Adoptive engineered T cell Trials to Achieve Cancer Killing ATTACKparticipant6.000.00016
2012-11-01Tumor Infiltrating Myeloid Cell Compartment TIMCCparticipant3.756.4698
2012-10-01Rational molecular Assessments and Innovative Drug Selection RAIDSparticipant5.999.64216
2012-03-01Principles of Chromatin Organization CHROMATINPRINCIPLESparticipant2.495.0801
2012-01-01Building data bridges between biological and medical infrastructures in Europe BIOMEDBRIDGESparticipant10.494.99925
2011-11-01European Research Training in the Ubiquitin Proteasome System UPStreamparticipant3.307.40910
2011-11-01CAncer Risk and INsulin analoGues CARINGparticipant2.974.1747
2011-11-01Decoding the ubiquitin code UBICODEparticipant1.498.2401
2011-06-01Innate and adaptive immune cell contribution to the pre-metastatic niche BMDCMETcoordinator184.0411
2011-05-01Mapping the life histories of T cells Life-his-Tparticipant2.499.6401
2011-04-01barcoding approach for dendritic cells differentiation BARDIFcoordinator176.1861
2011-04-01Adaptive and innovative Radiation Treatment FOR improving Cancer patients treatment outcomE ARTFORCEcoordinator5.994.71514
2011-03-01European collaborative project on Targeted therapy in renal cell cancer: genetic and tumor-related biomarkers for response and toxicity EuroTARGETparticipant5.999.55015
2011-02-01Epidemiological study to quantify risks for paediatric computerized tomography and to optimise doses EPI-CTparticipant2.998.59419
2011-01-01Modelling and predicting sensitivity to targeted therapies in colorectal cancers COLTHERESparticipant5.999.30011
2011-01-01Predicting long-term toxic effects using computer models based on systems characterization of organotypic cultures NOTOXparticipant4.849.98113
2011-01-01A European Platform for Translational Cancer Research EUROCANPLATFORMparticipant11.998.45428
2011-01-01Predicting individual response and resistance to VEGFR/mTOR pathway therapeutic intervention using biomarkers discovered through tumour functional genomics PREDICTparticipant5.841.00914
2011-01-01Rational Therapy for Breast Cancer: Individualized Treatment for Difficult-to-Treat Breast Cancer Subtypes RATHERparticipant5.995.7868
2011-01-01Protein stabilization by chemistry: total synthesis of an MHC class I scaffold PROCHEMcoordinator161.7491
2010-11-01"Spontaneous clearance in Patients acutely infected with HCV - Immune profiling, Novel biomarkers and X-omics approaches" SPHINXparticipant2.989.91010
2010-11-01European Infrastructure of Open Screening Platforms for Chemical Biology EU-OPENSCREENparticipant3.700.00023
2010-09-01Towards understanding and manipulation of MHC class II antigen presentation MHC CLASS II-OMICSparticipant2.112.3001
2010-08-01Functional genetic characterization of a mouse model of Glioma FGCMOGcoordinator161.2491
2010-07-01Breast Cancer Somatic Genetics Study BASISparticipant10.499.99915
2010-06-01DISSECTING GENETIC DEPENDENCIES IN CANCER FUNCTIONAL GENOMICSparticipant2.176.0001
2010-02-01The balance of ubiquitin conjugation and deconjugation Ubiquitin balanceparticipant2.299.7201
<< previous